Usefulness of Delayed Introduction of Tacrolimus in Kidney Transplants Using Type-III Donors After Circulatory Death.

Journal: Transplantation proceedings
PMID: 30879536

Abstract

INTRODUCTION: Our study compares 2 immunosuppressive strategies to reduce tacrolimus nephrotoxicity and its risk of acute tubular necrosis: delayed introduction of tacrolimus plus thymoglobulin vs initial tacrolimus plus basiliximab on the results of kidney transplant (KT) using type-III donation after circulatory death (III-DCD).

Authors

  • L Ruiz-Martínez
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: lararuizmartinez@gmail.com.
  • M De-Cos-Gómez
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • R Valero-San-Cecilio
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • E Rodrigo-Calabia
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • M Heras-Vicario
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • M Serrano-Soto
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • L Belmar-Vega
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • R Palomar-Fontanet
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • E Miñambres-García
    Intensive Care Unit, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • J C Ruiz-San-Millán
    Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Keywords

External Resources

Popular Topics
Recent Journals